首页> 外国专利> Xanthines substituted in position 8 as agents selectivosde Adenosine receptors.

Xanthines substituted in position 8 as agents selectivosde Adenosine receptors.

机译:黄嘌呤在第8位被取代,成为选择性选择腺苷的受体。

摘要

The invention refers to xantina derivatives that have selective reactions to adenosine receptors, which are the target countries of adenosine and give birth to children. From the study of in vitro fertilization, he knows that specific physiological effects can be distinguished as the result of this selectivity, which is caused by activitiesThe ptora of adenosine in vitro is related to the activity of adenosine in vivo. 3. The pharmaceutical formula of diphtheria compound can be developed according to the combination of various compounds mentioned in this specification, which will improve some physiological effects and reduce other effects.Like a drop in blood pressure, not a drop in heart rate
机译:本发明涉及对腺苷受体具有选择性反应的黄嘌呤衍生物,所述腺苷受体是腺苷的靶标国家并生育孩子。通过体外受精的研究,他知道这种选择性的结果是可以区分出特定的生理作用,这种选择性是由活性引起的。体外腺苷与体内腺苷的活性有关。 3.白喉化合物的药物配方可以根据本说明书中提到的各种化合物的组合来开发,这将改善某些生理作用并减少其他作用。就像降低血压,而不是降低心率

著录项

  • 公开/公告号MX9403382A

    专利类型

  • 公开/公告日1995-01-31

    原文格式PDF

  • 申请/专利权人 MERRELL DOW PHARMACEUTICALS INC.;

    申请/专利号MX19940003382

  • 发明设计人 PEET NORTON P.;LENTZ NELSEN L.;

    申请日1994-05-06

  • 分类号C07D471/22;

  • 国家 MX

  • 入库时间 2022-08-22 04:19:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号